Clinical Trial: An exploratory clinical study to evaluate the lipid-lowering effect of dihydroartemisinin tablets on patients with calcified aortic valve disease and hyperlipidemia at high risk. (China)

China, Oct. 28 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'An exploratory clinical study to evaluate the lipid-lowering effect of dihydroartemisinin tablets on patients with calcified aortic valve disease and hyperlipidemia at high risk.'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135251

Registration Time: 2026/10/27

Type: Interventional study

Primary Sponsor: Guang'anmen Hospital, China Academy of Chinese Medical Sciences

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=349434

Published by HT Digital Content Services with permission from Health Daily Digest....